W Y Almawi Selected Research

Calcineurin Inhibitors

9/2005

Tacrolimus (FK506) versus cyclosporine microemulsion (neoral) as maintenance immunosuppression therapy in kidney transplant recipients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Y Almawi Research Topics

Disease

6	Spontaneous Abortion (Miscarriage) 05/2014 - 08/2004
5	Habitual Abortion (Recurrent Miscarriage) 05/2014 - 03/2008
4	Infections 01/2019 - 02/2001
4	Type 2 Diabetes Mellitus (MODY) 12/2013 - 12/2007
3	Obesity 11/2010 - 12/2007
3	Ischemic Stroke 02/2010 - 06/2009
2	Pre-Eclampsia (Preeclampsia) 12/2018 - 01/2018
2	Rheumatoid Arthritis 01/2016 - 09/2015
2	Stroke (Strokes) 07/2009 - 06/2009
2	Sickle Cell Anemia (Hemoglobin S Disease) 03/2009 - 05/2008
2	Chronic Hepatitis C 10/2001 - 02/2001
2	Venous Thrombosis (Deep-Vein Thrombosis) 04/2001 - 09/2000
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Hemolysis 12/2018
1	HELLP Syndrome 12/2018
1	Acute Coronary Syndrome 02/2011
1	Delayed Graft Function 04/2010
1	Hypertension (High Blood Pressure) 04/2010
1	Lacunar Stroke 07/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 06/2009
1	Fever (Fevers) 03/2009
1	Acute Chest Syndrome 03/2009
1	Osteomyelitis 05/2008
1	Pregnancy Complications 03/2008
1	Insulin Resistance 12/2007
1	Hyperhomocysteinemia 02/2006
1	Leukocytosis (Pleocytosis) 04/2004
1	Venous Thromboembolism 04/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001

Drug/Important Bio-Agent (IBA)

6	AntibodiesIBA 07/2009 - 02/2001
5	Interleukin-10 (Interleukin 10)IBA 01/2018 - 12/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2015 - 03/2008
3	Annexin A5IBA 07/2009 - 08/2006
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 07/2009 - 08/2006
3	factor V LeidenIBA 08/2004 - 09/2000
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016 - 05/2008
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2013 - 02/2010
2	Cardiolipins (Cardiolipin)IBA 07/2009 - 11/2007
2	Phospholipids (Phosphatides)FDA LinkGeneric 07/2009 - 08/2004
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2009 - 05/2008
2	Protein CIBA 04/2004 - 09/2000
2	Factor V (Coagulation Factor V)IBA 04/2001 - 09/2000
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	EnzymesIBA 12/2018
1	Fas Ligand Protein (Fas Ligand)IBA 12/2018
1	AntigensIBA 01/2016
1	exostosin-2IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2012
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2012
1	plasma protein Z (protein Z)IBA 03/2012
1	InterleukinsIBA 02/2011
1	calpain 10IBA 11/2010
1	Glucose (Dextrose)FDA LinkGeneric 11/2010
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2010
1	PhosphatidylserinesIBA 07/2009
1	Immunoglobulin G (IgG)IBA 07/2009
1	Immunoglobulin M (IgM)IBA 07/2009
1	AnticoagulantsIBA 07/2009
1	AngiotensinogenIBA 06/2009
1	ReninIBA 06/2009
1	Plasminogen InactivatorsIBA 06/2009
1	Plasminogen Activator Inhibitor 1IBA 06/2009
1	HLA-DRB1*13:01:01 antigenIBA 03/2009
1	HLA-DQB1 antigen (HLA DQB1)IBA 05/2008
1	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2008
1	PPAR gammaIBA 12/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 12/2007
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 11/2007
1	Glycoproteins (Glycoprotein)IBA 11/2007
1	CytokinesIBA 12/2006
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 02/2006
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2005
1	Calcineurin InhibitorsIBA 09/2005
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2005
1	Prothrombin (Factor II)IBA 08/2004
1	Protein SIBA 04/2004
1	Antithrombin IIIIBA 04/2004
1	NucleotidesIBA 04/2001

Therapy/Procedure

2	Kidney Transplantation 04/2010 - 09/2005
1	Length of Stay 04/2010
1	Therapeutics 04/2010